Help protect yourself this season

Updated Novavax COVID-19 vaccine (2024-2025 Formula) now available.

Novavax Names New Executive Vice President, Research & Development

Dr. Draghia-Akli brings more that 20 years of expertise to support Novavax's transition to an R&D-focused organization.

Collaborating for a Future Free from the Grip of Malaria

As a result of years of dedicated research and effort, children receive the first doses of the R21/Matrix-MTM Malaria vaccine.

animated gif of the counties in Africa receiving R21/Matrix-M

Information about our vaccine for Healthcare Professionals

Visit our authorization website for information on ordering, efficacy, safety and other information.

Needle icon

Novavax's Investor Hub

Visit our Investor Hub to access investor resources and information on upcoming and past events. Sign up to receive notifications for investor updates, such as upcoming events and webcasts, daily closing stock price, SEC filings and press releases.

circle graph icon

Latest press releases

Blog

What is a protein-based vaccine?

Blog

Antibodies and immunity: Does vaccine protection last?

Blog

Why do we need an updated vaccine?